Panagiotis Tsourapas
Net Worth

Last updated:

What is Panagiotis Tsourapas net worth?

The estimated net worth of Mr. Panagiotis Tsourapas is at least $53,537,112 as of 4 Nov 2024. He owns shares worth $4,216,499 as insider, has earned $25,920,613 from insider trading and has received compensation worth at least $23,400,000 in Colgate-Palmolive Company.

What is the salary of Panagiotis Tsourapas?

Mr. Panagiotis Tsourapas salary is $1,950,000 per year as Group Pres of Colgate-Latin America, Asia Pacific & Africa/Eurasia in Colgate-Palmolive Company.

How old is Panagiotis Tsourapas?

Mr. Panagiotis Tsourapas is 60 years old, born in 1965.

What stocks does Panagiotis Tsourapas currently own?

As insider, Mr. Panagiotis Tsourapas owns shares in one company:

Company Title Shares Price per share Total value
Colgate-Palmolive Company (CL) Group Pres of Colgate-Latin America, Asia Pacific & Africa/Eurasia 49,172 $85.75 $4,216,499

What does Colgate-Palmolive Company do?

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

CL logo
CL
Colgate-Palmolive Company
$85.75

Panagiotis Tsourapas insider trading

Colgate-Palmolive Company

Mr. Panagiotis Tsourapas has made 20 insider trades between 2013-2024, according to the Form 4 filled with the SEC. Most recently he sold 20,032 units of CL stock worth $1,869,006 on 4 Nov 2024.

The largest trade he's ever made was exercising 40,000 units of CL stock on 31 Jul 2024. As of 4 Nov 2024 he still owns at least 49,172 units of CL stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 20,032 $93.3 $1,869,006
Option
Stock Option (Right to Buy) 14,794 $72.29 $1,069,458
Option
Common Stock 14,794 $72.29 $1,069,458
Sale
Common Stock 14,794 $102.94 $1,522,924
Sale
Common Stock 40,000 $99.47 $3,978,680
Option
Stock Option (Right to Buy) 40,000 $72.29 $2,891,600
Option
Common Stock 40,000 $72.29 $2,891,600
Sale
Common Stock 12,000 $94.16 $1,129,860
Option
Stock Option (Right to Buy) 12,000 $72.29 $867,480
Option
Common Stock 12,000 $72.29 $867,480
Option
Common Stock 30,433 $68.16 $2,074,313
Option
Stock Option (Right to Buy) 30,433 $68.16 $2,074,313
Sale
Common Stock 30,433 $84.41 $2,568,697
Option
Common Stock 15,000 $68.16 $1,022,400
Option
Stock Option (Right to Buy) 15,000 $68.16 $1,022,400
Sale
Common Stock 15,000 $77.83 $1,167,405
Sale
Common Stock 2,404 $81.01 $194,738
Option
Stock Option (Right to Buy) 13,698 $73 $999,954
Sale
Common Stock 13,698 $81.08 $1,110,579
Option
Common Stock 13,698 $73 $999,954
Option
Stock Option (Right to Buy) 20,000 $73 $1,460,000
Option
Common Stock 20,000 $73 $1,460,000
Sale
Common Stock 20,000 $80.78 $1,615,600
Option
Common Stock 35,000 $73 $2,555,000
Sale
Common Stock 35,000 $80.94 $2,832,760
Option
Stock Option (Right to Buy) 35,000 $73 $2,555,000
Option
Stock Option (Right to Buy) 35,976 $72.99 $2,625,888
Option
Common Stock 35,976 $72.99 $2,625,888
Sale
Common Stock 25,000 $81 $2,025,000
Option
Common Stock 25,000 $72.99 $1,824,750
Option
Stock Option (Right to Buy) 25,000 $72.99 $1,824,750
Option
Common Stock 11,714 $61.93 $725,448
Sale
Common Stock 11,714 $61.93 $725,448
Option
Stock Option (Right to Buy) 11,714 $61.93 $725,448
Option
Stock Option (Right to Buy) 15,000 $61.93 $928,950
Option
Common Stock 15,000 $61.93 $928,950
Sale
Common Stock 15,000 $61.93 $928,950
Option
Common Stock 7,500 $61.93 $464,475
Option
Stock Option (Right to Buy) 7,500 N/A N/A
Sale
Common Stock 7,500 N/A N/A
Sale
Common Stock 20,000 $61.93 $1,238,600
Option
Common Stock 20,000 N/A N/A
Option
Stock Option (Right to Buy) 20,000 $61.93 $1,238,600
Option
Common Stock 17,702 $64 $1,132,928
Sale
Common Stock 17,702 $64 $1,132,928
Option
Stock Option (Right to Buy) 17,702 $64 $1,132,928
Option
Stock Option (Right to Buy) 1,916 $76.5 $146,574
Option
Common Stock 1,916 $76.5 $146,574
Sale
Common Stock 1,916 $76.5 $146,574
Option
Common Stock 25,248 $64 $1,615,872
Option
Stock Option (Right to Buy) 25,248 $64 $1,615,872
Sale
Common Stock 25,248 $64 $1,615,872
Sale
Common Stock 1,458 $61.88 $90,222
Sale
Common Stock 449 $59.62 $26,769